✦ LIBER ✦

Efficacy assessment of a new clotting factor concentrate in haemophilia A patients, including prophylactic treatment

✍ Scribed by I. DEN UIJL; E. P. MAUSER-BUNSCHOTEN; G. ROOSENDAAL; R. SCHUTGENS; K. FISCHER

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment decisions and usage of clottin

✍ S. DHARMARAJAN; P. GUND; S. PHADNIS; S. LOHADE; A. LALWANI; A. KAR 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 63 KB

Prophylactic treatment of haemophilia pa

✍ M. MORFINI; G. AUERSWALD; R. A. KOBELT; G. F. RIVOLTA; J. RODRIGUEZ-MARTORELL; F 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 471 KB

Clinical assessment of Optivate®, a high

✍ A. DMOSZYNSKA; K. KULICZKOWSKI; A. HELLMANN; J. TRELINSKI; J. KLOCZKO; T. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 110 KB

A clinical study assessing the pharmacok

✍ T. LISSITCHKOV; M. MATYSIAK; K. ZAVILSKA; P. ŁAGUNA; L. GERCHEVA; A. ANTONOV; N. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 113 KB

Prophylactic treatment with activated pr

✍ C. A. LEISSINGER; D. L. BECTON; N. P. EWING; L. A. VALENTINO 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 449 KB

Clinical efficacy, safety and pharmacoki

✍ D. M. Wolf; R. Rokicka-Milewska; S. Lopaciuk; A. B. Skotnicki; A. Klukowska; P. 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB